Generate Biomedicines, Inc. (GENB)

Generate Biomedicines, Inc. is a clinical-stage biotechnology company that uses generative artificial intelligence to design novel protein therapeutics. Its platform combines machine learning models trained on protein structure and function with high-throughput laboratory experimentation, aiming to create antibodies, peptides and other protein drugs with tailored properties.

The company is advancing a pipeline of drug candidates in areas such as immunology, infectious disease and oncology, and it has formed research collaborations with large pharmaceutical companies. Generate Biomedicines was founded by Flagship Pioneering and is based in Somerville, Massachusetts. Its common stock trades on the Nasdaq.